WEST CHESTER, PA / ACCESSWIRE / December 8, 2020 / Virpax® Pharmaceuticals Inc. (“Virpax”), a company specializing in developing pharmaceutical products for pain management, today announced that based on recent ex-vivo studies, MMS019, a high-density mucoadhesive polymer, has demonstrated reduction…